公开(公告)号：US20150190438A1

公开(公告)日：2015-07-09

申请号：US14413303

申请日：2013-07-09

Applicant: S.P.M.D.

Inventor： Adrien Nivoliez

IPC: A61K35/747 ,  A61K9/00 ,  A61F13/20 ,  C12R1/225

CPC classification number: A61K35/747 ,  A61F13/2074 ,  A61K9/0036 ,  C12N1/20 ,  C12R1/225

Abstract: The disclosure relates to an isolated strain of Lactobacillus crispatus, identified as IP174178 and deposited at the CNCM under number 1-464 or an isolated strain having the same characteristics as IP174178. The disclosure also relates to a pharmaceutical composition or a nutraceutical composition including such a strain, and to the use thereof for the treatment or prevention of genital infections.

Abstract translation: 本公开内容涉及确定为IP174178并在数量为1-464的CNCM处分离或具有与IP174178相同特征的分离菌株的分离的烟草乳杆菌菌株。 本公开还涉及包含这种菌株的药物组合物或营养组合物，以及其用于治疗或预防生殖器感染的用途。

公开(公告)号：US20230190839A1

公开(公告)日：2023-06-22

申请号：US17925842

申请日：2021-05-18

Applicant: GYNOV ,  S.P.M.D.

Inventor： PIERRE-YVES MOUSSET

IPC: A61K36/064 ,  A61P15/08 ,  A61K31/05 ,  A61K36/9066 ,  A61K31/733 ,  A61K33/30 ,  A61K31/121 ,  A61K36/28 ,  A23L33/00 ,  A23L33/105 ,  A23L33/14 ,  A23L33/125 ,  A23L33/15 ,  A23L33/16 ,  A23L33/135

CPC classification number: A61K36/064 ,  A61P15/08 ,  A61K31/05 ,  A61K36/9066 ,  A61K31/733 ,  A61K33/30 ,  A61K31/121 ,  A61K36/28 ,  A23L33/40 ,  A23L33/105 ,  A23L33/14 ,  A23L33/125 ,  A23L33/15 ,  A23L33/16 ,  A23L33/135

Abstract: The present invention relates to the use of a combination of a yeast of the species Saccharomyces cerevisiae, resveratrol and a curcuma extract, for use in the management of a subject who has endometriosis or is susceptible to endometriosis. The combination according to the invention may be used in the treatment or prevention of endometriotic lesions in a subject who has endometriosis or is susceptible to endometriosis, for example to slow the development or to reduce the endometriotic lesions. It may also be used in the treatment or prevention of one or more symptoms or disorders associated with endometriosis. The invention also relates to pharmaceutical or nutraceutical compositions and kits based on said combination.